Compare MYGN & PANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MYGN | PANL |
|---|---|---|
| Founded | 1991 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 444.2M | 485.4M |
| IPO Year | 1996 | 2015 |
| Metric | MYGN | PANL |
|---|---|---|
| Price | $3.07 | $8.14 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | $7.64 | ★ $9.00 |
| AVG Volume (30 Days) | ★ 2.7M | 359.9K |
| Earning Date | 05-05-2026 | 05-08-2026 |
| Dividend Yield | N/A | ★ 2.63% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.36 |
| Revenue | ★ $771,400,000.00 | $385,088,209.00 |
| Revenue This Year | $6.86 | $0.72 |
| Revenue Next Year | $5.45 | N/A |
| P/E Ratio | ★ N/A | $22.61 |
| Revenue Growth | ★ 2.33 | N/A |
| 52 Week Low | $2.74 | $4.56 |
| 52 Week High | $8.59 | $9.39 |
| Indicator | MYGN | PANL |
|---|---|---|
| Relative Strength Index (RSI) | 33.79 | 64.73 |
| Support Level | $2.74 | $7.99 |
| Resistance Level | $3.33 | $8.43 |
| Average True Range (ATR) | 0.15 | 0.24 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 58.08 | 93.81 |
Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
Pangaea Logistics Solutions Ltd and its subsidiaries collectively, Pangaea or the Company, provide seaborne drybulk logistics and transportation services as well as terminal and stevedoring services. Pangaea utilizes its logistics expertise to service a broad base of industrial customers who require the transportation of a wide variety of dry bulk cargoes, including grains, coal, iron ore, pig iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The Company's operating segments include the shipping segment: The Company's operating segments include the shipping segment and six terminal and stevedoring operating segments. The company operates in the USA, Germany, Canada, Singapore, the United Kingdom, and other countries, with maximum from the USA and others.